Valion Bio, Inc. (VBIO)
NASDAQ: VBIO · Real-Time Price · USD
0.7600
+0.0100 (1.33%)
At close: Jun 5, 2026, 4:00 PM EDT
0.6817
-0.0783 (-10.30%)
Pre-market: Jun 8, 2026, 5:51 AM EDT
Valion Bio Employees
Valion Bio had 52 employees as of December 31, 2025. The number of employees increased by 45 or 642.86% compared to the previous year.
Employees
52
Change (1Y)
45
Growth (1Y)
642.86%
Revenue / Employee
n/a
Profits / Employee
-$261,115
Market Cap
2.39M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 52 | 45 | 642.86% |
| Dec 31, 2024 | 7 | -2 | -22.22% |
| Dec 31, 2023 | 9 | -7 | -43.75% |
| Jun 30, 2023 | 11 | - | - |
| Dec 31, 2022 | 16 | 9 | 128.57% |
| Dec 31, 2021 | 7 | -1 | -12.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Jaguar Health | 47 |
| Calidi Biotherapeutics | 29 |
| Silexion Therapeutics | 14 |
| VivoSim Labs | 14 |
| Azitra | 13 |
| Biodexa Pharmaceuticals | 11 |
| Ensysce Biosciences | 10 |
| Adial Pharmaceuticals | 5 |
VBIO News
- 10 days ago - Valion Bio Transcript: AGM 2026 - Transcripts
- 19 days ago - VALION BIO BRIEFS SENIOR DEPARTMENT OF WAR AND BARDA OFFICIALS IN JOINT ENGAGEMENT ON ENTOLIMOD FOR ACUTE RADIATION SYNDROME - PRNewsWire
- 24 days ago - Valion Bio’s Velocity Bioworks licenses LarmorBio’s BioScan-NMR platform - TheFly
- 24 days ago - Valion Bio reports Q1 EPS ($2.23) vs. ($2.52) last year - TheFly
- 24 days ago - Valion Bio's Velocity Bioworks Secures Exclusive Commercial License to LarmorBio's BioScan-NMR™ Platform - PRNewsWire
- 24 days ago - Valion Bio Earnings Call Transcript: Q1 2026 - Transcripts
- 24 days ago - Valion Bio Earnings release: Q1 2026 - Filings
- 24 days ago - Valion Bio Quarterly report: Q1 2026 - Filings